{
    "clinical_study": {
        "@rank": "6554", 
        "arm_group": [
            {
                "arm_group_label": "Preterm infants with IVH Grades I-II", 
                "description": "Preterm infants (post-menstrual age 24-35 weeks) who were diagnosed with IVH Grades 1-2 in the neonatal intensive care unit (NICU)."
            }, 
            {
                "arm_group_label": "Control Group", 
                "description": "Preterm infants (post-menstrual age 24-35 weeks) who had no imaging evidence  of IVH in the neonatal intensive care unit (NICU)."
            }
        ], 
        "brief_summary": {
            "textblock": "It is well-known that preterm delivery can be accompanied by complications.  One of these\n      complications is Intraventricular Hemorrhage (IVH).  There are four degrees of IVH,\n      according to severity.  It is known that IVH Grades 3-4 can cause severe neurodevelopmental\n      outcomes, including cerebral palsy (CP), hemiplegia, lower motor and cognitive skills and\n      social difficulties.  It is not known whether IVH Grades I-II have any of these effects and\n      the aim of this study is to determine whether they do have any neurodevelopmental outcomes."
        }, 
        "brief_title": "The Long-term Neurodevelopmental Outcome After Intraventricular Hemorrhage (IVH)-Grades I-II in Preterm Infants at Ages 1-7 Years", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Premature Infants", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  All preterm infants born at 35 weeks or less\n\n          -  Underwent at least 1 brain ultrasound\n\n          -  Diagnosed with IVH Grades 1-2\n\n          -  Had no other severe illness in NICU\n\n          -  Had neurodevelopmental follow-up\n\n        Exclusion Criteria:\n\n          -  All others"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "7 Years", 
            "minimum_age": "1 Year", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Preterm infants born in 2007-2011 at the Hillel Yaffe Medical Center"
            }
        }, 
        "enrollment": {
            "#text": "700", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01912703", 
            "org_study_id": "HYMC-297-13"
        }, 
        "intervention": {
            "arm_group_label": [
                "Preterm infants with IVH Grades I-II", 
                "Control Group"
            ], 
            "description": "Subjects with incomplete data will be asked to complete a telephone interview", 
            "intervention_name": "Telephone interview", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "July 30, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Hadera", 
                    "country": "Israel", 
                    "zip": "38100"
                }, 
                "name": "Hillel Yaffe Medical Center"
            }
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_groups": "2", 
        "overall_contact": {
            "email": "roeiabra@gmail.com", 
            "last_name": "Roei Abramovitch, MD", 
            "phone": "972-50-3205548"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Retrospective study of preterm infants born in the years 2007-2011 and suffered IVH Grades 1-2 who have undergone a general neurodevelopmental assessment in the Institute for Child Development in Hillel Yaffe Medical Center at ages 1-7.  This assessment will indicate whether IVH Grades 1-2 has any neurodevelopmental effect on these children.", 
            "measure": "General Neurodevelopmental Assessment", 
            "safety_issue": "No", 
            "time_frame": "Seven years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01912703"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Hillel Yaffe Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hillel Yaffe Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "July 2013"
    }
}